Two good pieces by Brad Setser at the Council on Foreign Relations – see links
• The issue for Pharma is not where factories are located but where the Intellectual Property rights reside
• Large international companies use transfer pricing to avoid paying tax on US sales. It is even possible to report losses on US sales to earn a tax rebate.
• When asked “who is most affected?”, it’s hard to say. The fact is the entire industry seeks to optimise tax treatment by transferring profit abroad.
Find more articles and bullets on these widgets:
MNI looks at the BOJ's view of surging bond yields -- On MNI Policy MainWire now, for more details please contact sales@marketnews.com
This morning’s January activity data has not been a material driver of upside in SEK crosses intraday. More weight will be placed on the firmer-than-expected Norwegian February CPI report (for NOKSEK) and the pullback in European equities (for EURSEK). However, the dip in household consumption will be worth monitoring in the months ahead. When taken alongside the weak February Economic Tendency Indicator consumer confidence reading, there are some downside risks to Q1 consumption after a solid Q4.
Source: EMMI/Bloomberg